Treatment of CIA Mice with FGF21 Down-regulates TH17-IL-17 Axis
Overview
Pathology
Authors
Affiliations
Recently, FGF21 was reported to play an important role in anti-inflammation. The aim of the study is to explore the mechanism for FGF21 alleviating inflammation of CIA. CIA mice were injected with FGF21 once a day for 28 days after first booster immunization. The results showed that FGF21 alleviates arthritis severity and decreases serum anti-CII antibodies levels in CIA mice. Compared with CIA model, the number of the splenic TH17 cells was significantly decreased in FGF21-treated mice. FGF21 treatment reduced the mRNA expression of IL-17, TNF-α, IL-1β, IL-6, IL-8, and MMP3 and increased level of IL-10 in the spleen tissue. The expression of STAT3 and phosphorylated STAT3 was suppressed in FGF21-treated group. The mRNA expression of RORγt and IL-23 also decreased. In conclusion, these findings suggest that the beneficial effects of FGF21 on CIA mice were achieved by down-regulating Th17-IL-17 axis through STAT3/RORγt pathway. Modulating of Th17-mediated inflammatory response may be one of the mechanisms for FGF21 attenuating inflammation in CIA.
Interorgan communication with the liver: novel mechanisms and therapeutic targets.
Zhao J, Zhang X, Li Y, Yu J, Chen Z, Niu Y Front Immunol. 2023; 14:1314123.
PMID: 38155961 PMC: 10754533. DOI: 10.3389/fimmu.2023.1314123.
Mechanism of fibroblast growth factor 21 in cardiac remodeling.
Zhao Z, Cui X, Liao Z Front Cardiovasc Med. 2023; 10:1202730.
PMID: 37416922 PMC: 10322220. DOI: 10.3389/fcvm.2023.1202730.
The role of Th17 cells in endocrine organs: Involvement of the gut, adipose tissue, liver and bone.
Zi C, Wang D, Gao Y, He L Front Immunol. 2023; 13:1104943.
PMID: 36726994 PMC: 9884980. DOI: 10.3389/fimmu.2022.1104943.
Li S, Li X, Fan J, Jia X, Wang H, Dong F J Nat Med. 2022; 76(4):765-773.
PMID: 35534765 DOI: 10.1007/s11418-022-01626-1.
New developments in the biology of fibroblast growth factors.
Ornitz D, Itoh N WIREs Mech Dis. 2022; 14(4):e1549.
PMID: 35142107 PMC: 10115509. DOI: 10.1002/wsbm.1549.